| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 10/03/2006 | US7115248 Conjugates of an annexin, a NxSy or a N4 chelating compound, and a hexose moiety recognized by a mammalian liver receptor that is conjugated to the annexin directly or via the chelating compound; useful for imaging vascular thrombi |
| 10/03/2006 | CA2275419C Mucosal administration of substances to mammals |
| 09/28/2006 | WO2006102557A2 Treatment of protein degradation disorders |
| 09/28/2006 | WO2005072252A3 Isotopically-enriched boranes and methods of preparing them |
| 09/28/2006 | WO2004070352A3 Methods, mixtures, kits and compositions pertaining to analyte determination |
| 09/28/2006 | US20060216770 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus |
| 09/28/2006 | US20060216237 Inhibition of angiogenesis and tumor development by IGFBP-4 |
| 09/28/2006 | US20060216236 Methods of inhibiting alphavBeta3-mediated angiogenesis and tumor development |
| 09/28/2006 | US20060216235 Monoclonal antibody or cellular cytotoxicity inducing ligand that competitively inhibits binding of isolated monoclonal antibody encoded by clone accession number PTA-5643 to its target antigen |
| 09/28/2006 | US20060216234 Cancerous disease modifying antibodies |
| 09/28/2006 | US20060216233 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 09/28/2006 | US20060216232 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 09/28/2006 | US20060216231 Methods for diagnosing and treating tumors and suppressing cd promoters |
| 09/28/2006 | US20060216230 Radioactive bone cement for treatment of tumors in bone |
| 09/28/2006 | CA2602946A1 Delivery systems and methods for diagnosing and treating cardiovascular diseases |
| 09/28/2006 | CA2601706A1 Treatment of protein degradation disorders |
| 09/27/2006 | EP1705487A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 09/27/2006 | EP1704864A2 Process for producing an injectable pharmaceutical preparation |
| 09/27/2006 | EP0759786B1 Somatostatin binding peptide-metal chelate conjugates |
| 09/27/2006 | CN1836639A Apparatus for therapeutic emr treatment of the skin |
| 09/26/2006 | US7112318 Phosphonium or quaternary ammonium salts labeled with 11C, 18F,76Br, or 123I; for positron emission tomography; capable of measuring mitochondrial surface potential; localize into dysfunctional mitochondria |
| 09/26/2006 | US7112317 Administering a targeting agent operatively attached to a therapeutic agent; the targeting agent recognizes and binds to a tumor-associated endothelial cell marker. |
| 09/26/2006 | CA2243316C Metal complexes that contain perfluoroalkyl, process for their production and their use in nmr diagnosis |
| 09/21/2006 | WO2006072336A3 Radioactive metal complexes based on bispidine and derivatives thereof |
| 09/21/2006 | WO2006042240A3 Immunotherapy of autoimmune disorders |
| 09/21/2006 | US20060210475 Humanized L243 antibodies |
| 09/21/2006 | US20060210474 Customization of cancer therapy by adminstering modifying antibodies from antigens expressed from cancerous tissue which are cytotoxic to cancer cells while non-toxic to non-cancerous cells; monoclonal antibody antigen binding fragment having identifying characteristics to a cloned deposit |
| 09/21/2006 | US20060210473 VEGF-conjugate combined methods for tumor vasculature targeting and tumor treatment |
| 09/20/2006 | EP1701745A1 Gas-filled microvesicle assembly for contrast imaging |
| 09/20/2006 | CN1834085A Trilerium and trilerium marked agmatine and application in biochemistry and medicine research |
| 09/20/2006 | CN1275976C 99m TCN nuclear mark compound, its preparation and application |
| 09/19/2006 | US7110808 Method of optimizing radiosurgery and radiotherapy with metalloporphyrins |
| 09/19/2006 | US7109351 Fused pyrrolecarboxamides; GABA brain receptor ligands |
| 09/19/2006 | US7109304 Humanized anti-CD19 antibodies |
| 09/19/2006 | US7109179 Methods and compositions comprising DNA damaging agents and p53 |
| 09/19/2006 | US7109167 Tetrapeptide |
| 09/19/2006 | US7108846 Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection |
| 09/19/2006 | US7108845 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents |
| 09/19/2006 | US7108844 Use of stabilized oligonucleotides for preparing a medicament with antitumor activity |
| 09/19/2006 | CA2235269C Monoclonal antibody br110 and uses thereof |
| 09/14/2006 | WO2006096710A2 Detection, imaging, and depletion of chlamydia |
| 09/14/2006 | WO2006096656A2 Methods of applying ionization radiation for therapy of hiv infection |
| 09/14/2006 | WO2006096499A2 Mr coronary angiography with a fluorinated nanoparticle contrast agent at 1.5 t |
| 09/14/2006 | WO2006096393A2 Coagulator with gamma ray detector |
| 09/14/2006 | WO2006096207A2 Methods for preparing multivalent constructs for therapeutic and diagnostic applications |
| 09/14/2006 | WO2006094725A1 Chelators for radioactively labeled conjugates comprising a stabilizing sidechain |
| 09/14/2006 | WO2006037036A3 Quantitative proteomics with isotopic substituted raman active labeling |
| 09/14/2006 | WO2005100612A3 Bacteriophage imaging of inflammation |
| 09/14/2006 | WO2005086875A3 A humanized anti-cea t84.66 antibody and uses thereof |
| 09/14/2006 | WO2005053603A3 Antigen receptor variable region typing |
| 09/14/2006 | US20060205967 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |
| 09/14/2006 | US20060204565 comprises a folate receptor ligand capable of binding to activated macrophages or a vitamin/vitamin-receptor binding analog and immunogen, a cytotoxin, or another compound capable of altering macrophage function |
| 09/14/2006 | US20060204439 Administering isotope labeled water to tissue; measurement, calibration |
| 09/14/2006 | US20060204437 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| 09/14/2006 | US20060204436 Tritiated growth hormone secretagogue mk-0677 |
| 09/14/2006 | US20060204435 Detection, imaging, and depletion of intracellular pathogens |
| 09/14/2006 | CA2600743A1 Coagulator with gamma ray detector |
| 09/14/2006 | CA2575730A1 Methods for preparing multivalent constructs for therapeutic and diagnostic applications |
| 09/13/2006 | EP1700608A1 Chelators for radioactively labeled conjugates comprising a stabilizing sidechain |
| 09/13/2006 | EP1700573A2 Apparatus for therapeutic EMR treatment of the skin |
| 09/13/2006 | EP1699495A2 Conjugates of angiotensin ii and an imaging moiety |
| 09/13/2006 | EP1699494A2 Contrast agent imaging angiotensin ii receptors |
| 09/13/2006 | EP1699418A2 Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 09/13/2006 | EP1506027B1 Cell delivery fluid for prevention of cell settling in delivery system |
| 09/13/2006 | EP1196154B1 Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine |
| 09/13/2006 | EP1163272B1 Antibodies specific for cyp1b1 |
| 09/13/2006 | CN1831007A Sythesis of sugar substituted MAVgn, 99Tcm and 186Re tag and application of said tag |
| 09/13/2006 | CN1831006A Sugar substituted MAAGn synthesis, 99Tcm or 186Rc tag and tag in application of radiation medicine for treating tumor |
| 09/13/2006 | CN1831005A Synthesis of sugar substituted MAGn, and 99Tcm or 186 Re tag and tag, application for tumor medicine thereof |
| 09/13/2006 | CN1831002A Synthesis of novel adenosine polypeptide compounds, and 99Tcm, 186Re tag and tag, and application in tumor treating medicines |
| 09/13/2006 | CN1831000A Synthesis of novel imurel substituted peptide compounds, and 99Tcm, 186 Re tagging, and tumor medicine, anoxic imaging agent |
| 09/13/2006 | CN1830989A Novel adenine polypeptide compounds synthesis and 99Tcm, 186Re tagging and the tag used in tumor and anoxic visulization |
| 09/13/2006 | CN1274367C Rhenium nuclide labelled dimercapto succinic acid preparation kit and its preparing method |
| 09/12/2006 | US7105678 Boat tropanes |
| 09/12/2006 | US7105160 Antibody-serum protein hybrids |
| 09/12/2006 | US7105149 Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/myeloma |
| 09/12/2006 | CA2347670C Radiolabeled somatostatin-derived peptides for imaging |
| 09/08/2006 | WO2006092902A1 Radioactive halogen-labeled phenyloxyaniline derivatives |
| 09/08/2006 | WO2006092584A2 Radioisotope labelled biological compositions, and their use in accelerator mass spectrometry |
| 09/08/2006 | WO2006074129A3 Agents for therapy efficacy monitoring and deep tissue imaging |
| 09/08/2006 | CA2599520A1 Radioisotope labelled biological compositions, and their use in accelerator mass spectrometry |
| 09/08/2006 | CA2599321A1 Radioactive halogen-labeled phenyloxyaniline derivatives |
| 09/07/2006 | WO2005034926A9 Non-invasive system for detecting skin cancer |
| 09/07/2006 | US20060198786 Glycopeptide compositions |
| 09/07/2006 | US20060198785 Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes |
| 09/07/2006 | US20060198784 Methods of treatment using antibodies to Neutrokine-alpha |
| 09/07/2006 | US20060198783 Porphyrin-based compounds for tumor imaging and photodynamic therapy |
| 09/07/2006 | US20060198772 Method for producing actinium-225 |
| 09/07/2006 | DE102005008765A1 Kontrastmittel auf der Basis von Bakteriophagen, Verwendung und Verfahren zu deren Herstellung Contrast agents based on bacteriophages, use and process for their preparation |
| 09/06/2006 | EP1698351A2 Glycopeptide compositions |
| 09/06/2006 | EP1698350A1 Porphyrin-based compounds for tumor imaging and photodynamic therapy |
| 09/06/2006 | EP1697280A1 Methods for carbon isotope labeling synthesis of ketones and amines by suzuki coupling reactions using carbon-isotope monoxide |
| 09/06/2006 | EP1696965A1 Assembly of gas-filled microvesicle with active component for contrast imaging |
| 09/06/2006 | EP1173224B1 Polyethyleneimine:dna formulations for aerosol delivery |
| 09/06/2006 | CN1829735A Imaging agents |
| 08/31/2006 | WO2006091552A1 Dosage and method for attaining beneficial levels of vitamin d3 |
| 08/31/2006 | US20060195176 Polymer containing immunosuppressant and antiproliferative agent coating of stent |
| 08/31/2006 | US20060194717 reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release; side effect reduction |
| 08/31/2006 | US20060194716 Polyacid glycopeptide derivatives |
| 08/31/2006 | US20060193871 transmission and, or amplification of signal; oral or enteric administering, dissolving, absorption; peptide yy; obesity therapy |